Jacob Kilstein Analyst PerformanceAnalyst at ArgusJacob Kilstein is a stock analyst at Argus across a range of sectors, covering 13 publicly traded companies. Over the past year, Jacob Kilstein has issued 1 stock ratings, including and hold recommendations. While full access to Jacob Kilstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jacob Kilstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 10 YearsBuy Recommendations84.00% 21 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Jacob Kilstein.RatingPercentageCount Strong Buy0.0%0 ratings Buy84.0%21 ratings Hold16.0%4 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Jacob Kilstein at Argus, the majority (84.0%) have been Buy recommendations, followed by 16.0% Hold.Best & Worst CallsBest Call000.0%SREJun 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SPGAug 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE84.6% of companies on NYSE11 companiesNASDAQ15.4% of companies on NASDAQ2 companiesJacob Kilstein, an analyst at Argus, currently covers 13 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageFinance7 companies53.8%Utilities3 companies23.1%Medical2 companies15.4%Construction1 company7.7%Jacob Kilstein of Argus specializes in stock coverage within the Finance sector, with additional focus on Utilities and Medical companies.Coverage IndustriesIndustryPercentageINS - MULTI LINE2 companies15.4%UTIL - ELEC PWR2 companies15.4%REIT - EQTY TRUST - RETAIL2 companies15.4%UTIL - GAS DISTR1 company7.7%REIT - EQTY TRUST - OTHER1 company7.7%MED - BIOMED/GENE1 company7.7%REIT - EQTY TRUST - RESID1 company7.7%INS - LIFE1 company7.7%LARGE CAP PHARMA1 company7.7%BLDG PRD - WOOD1 company7.7% Jacob Kilstein's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPRUPrudential Financial6/9/2026Downgrade$103.81Hold$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialDeutsche Bank AktiengesellschaftBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
